BioCentury
ARTICLE | Financial News

Cytomyx lists on AIM

May 29, 2001 7:00 AM UTC

Discovery research and functional genomics company Cytomyx (LSE:CYX) completed its IPO on London's AIM market on Tuesday, selling 9.4 million shares at 4p, valuing the company at L7.2 million ($10.3 m...